Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI

被引：1
|
作者：
Han, Jiefei [1 ]
Zhang, Qiuyi [2 ,3 ]
Wang, Binchao [2 ,3 ]
Zhou, Qing [2 ,3 ]
Yan, Lixu [2 ,3 ]
Zhang, Zhou [4 ]
Chen, Huajun [2 ,3 ]
Su, Jian [2 ,3 ]
Xie, Zhi [2 ,3 ]
Niu, Feiyu [2 ,3 ]
Wu, Yi Long [2 ,3 ]
Chuai, Shannon [4 ]
Yang, Jinji [2 ,3 ]
Dong, Zhong-Yi [2 ]
机构：
[1] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[3] Guangdong Acad Med Sci, Guangdong Key Lab Lung Canc Translat Med, Guangzhou, Guangdong, Peoples R China
[4] Burning Rock Dx Ltd, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
SCLC; transformation; EGFR-TKI; NSCLC;
D O I：
10.1016/j.jtho.2016.11.1784
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-116
引用
收藏
页码：S1263 / S1264
页数：2
相关论文
共 50 条
  • [1] Molecular mechanism of transformation from adenocarcinoma to small-cell lung cancer after EGFR-TKI
    Han, J.
    Zhang, Q.
    Wang, B.
    Zhou, Q.
    Zhang, Z.
    Chuai, S.
    Yang, J-J.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Molecular mechanism of transformation from adenocarcinoma to small-cell lung cancer after EGFR-TKI.
    Han, Jie-Fei
    Zhang, Qiu-Yi
    Wang, Bin-Chao
    Zhou, Qing
    Yan, Li-Xu
    Chen, Huajun
    Wang, Zhen
    Tu, Hai-Yan
    Su, Jian
    Xie, Zhi
    Niu, Fei-Yu
    Wu, Yi-Long
    Yang, Jin-Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Small cell transformation of lung adenocarcinoma in acquired resistance to EGFR-TKI
    So, Kwang Sup
    Choi, Yun Jung
    Kim, Sun Ye
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Woo Sung
    Rho, Jin Kyung
    CANCER RESEARCH, 2013, 73 (08)
  • [4] ProGRP as early predictive marker of non-small-cell lung cancer to small-cell lung cancer transformation after EGFR-TKI treatment
    Kato, Yasuhiro
    Tanaka, Yosuke
    Hino, Mitsunori
    Gemma, Akihiko
    RESPIRATORY MEDICINE CASE REPORTS, 2019, 27
  • [5] NOTCH alteration in EGFR-mutated lung adenocarcinoma leads to histological small-cell carcinoma transformation under EGFR-TKI treatment
    Koba, Hayato
    Kimura, Hideharu
    Yoneda, Taro
    Ogawa, Naohiko
    Tanimura, Kota
    Tambo, Yuichi
    Sone, Takashi
    Hosomichi, Kazuyoshi
    Tajima, Atsushi
    Kasahara, Kazuo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (11) : 4161 - +
  • [6] Etoposide/platinum plus anlotinib for patients with transformed small-cell lung cancer from EGFR-mutant lung adenocarcinoma after EGFR-TKI resistance: a retrospective and observational study
    Ding, Jianghua
    Leng, Zhaohui
    Gu, Hong
    Jing, Xiang
    Song, Yun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Peritoneal relapse from lung adenocarcinoma after a response to EGFR-TKI
    Satoh, Hiroaki
    Kagohashi, Katsunori
    Kurishima, Koichi
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2013, 61 (04): : 346 - 347
  • [8] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] EGFR-TKI FOR LUNG CANCER
    Bai, Chunxue
    RESPIROLOGY, 2010, 15 : 23 - 23
  • [10] Lung Adenocarcinoma Transformation into Small-Cell Lung Cancer after Treatment: Clinical Evidence and the Exploratory Mechanism
    Wang, Jie
    Zhong, Jia
    Zhao, Jun
    Bai, Hua
    Wang, Shuhang
    Yang, Xiandan
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S321 - S321
12345